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Abstract   
 
 
Dental pulp tissue represents a source of mesenchymal stem cells (MSCs) that have a 
strong differentiation potential towards the osteogenic lineage. The objective of the 
current study was to examine in vitro osteogenic induction of dental pulp stem cells 
(DPSCs) cultured on hydrogel scaffolds derived from decellularized bone extracellular 
matrix (bECM) compared to collagen type I (Col-I), the major component of bone matrix. 
DPSCs in combination with bECM hydrogels were cultured under three different 
conditions: basal medium, osteogenic medium and medium supplemented with growth 
factors (GFs) and cell growth, mineral deposition, gene and protein expression were 
investigated. The DPSCs/bECM hydrogel constructs cultured in basal medium showed 
that cells were viable after three weeks and that the expression of runt-related 
transcription factor 2 (RUNX-2) and bone sialoprotein (BSP) were significantly 
upregulated in the absence of extra osteogenic inducers compared to Col-I hydrogel 
scaffolds. In addition, the protein expression levels of BSP and osteocalcin (OCN) were 
higher on bECM with respect to Col-I hydrogel scaffolds. Furthermore, DPSCs/bECM 
hydrogels cultured with osteogenic or GFs supplemented medium displayed a higher 
upregulation of the osteo-specific markers compared to Col-I hydrogels in identical 
media. Collectively, our results demonstrate that bECM hydrogels might be considered 
as suitable scaffolds to support osteogenic differentiation of DPSCs.  
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1. Introduction 
 
 
 
Current treatment options to repair bone defects due to trauma, degenerative diseases, 
severe infections and tumours are based on autologous or allogeneic bone grafts.[1,2] 
Although autologous bone grafts remain the gold standard, they are limited by morbidity 
at the donor site and availability of graft material.[3,4] Allogeneic bone grafts may 
provide an alternative treatment, but the risk of potential immunogenic responses, disease 
transmission, reduced osteoinductive characteristics, availability limitations and 
ethical/religious issues limit their use.[3,4] Hence, there is the need for alternative 
materials to treat bone defects.[5,6].  
Recent research has attempted to identify synthetic or natural materials which mimic the 
properties of the native bone microenvironment to act as bone graft substitutes.[7-9] 
Natural materials, including collagen and scaffolds composed of the extracellular matrix 
have recently been considered as cell delivery systems for bone repair.[10]  
Cell-matrix interactions induce signalling essential for cell behaviour, making ECM 
composition a crucial factor in stem cell differentiation.[11,12] Proliferation and lineage-
specific differentiation of mesenchymal stem cells (MSCs) are triggered by various 
factors including the ECM.[13] Thus, several studies have proposed the use of biological 
scaffolds composed of decellularized ECM to induce osteogenic differentiation of 
MSCs.[14,15]  
ECM scaffolds consist of functional and structural proteins such as laminin and collagen, 
along with growth factors, proteoglycans, glycosaminoglycans and glycoproteins.[16] 
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While there are several common ECM components, the detailed composition of the ECM 
varies for each tissue type.[17] ECM scaffolds derived from bone are principally 
composed of collagen type I, with smaller amounts of collagen III, collagen V and 
adhesion proteins such as fibronectin, vitronectin and proteoglycans such as decorin and 
hyaluronan.[18] Bone ECM also contains pro-inflammatory cytokines, growth factors of 
the TGF-β family, several BMPs, FGFs, and angiogenic growth factors including 
VEGF.[7] 
In this context, it was recently reported that tissue-specific hydrogels derived from 
decellularized and demineralized bovine bone extracellular matrix (bECM) possess 
distinct mechanical and biological properties, including osteogenic functionality and have 
the potential for clinical use in the near future.[19] 
More recently, we showed that bECM hydrogel scaffolds were also able to stimulate 
odontogenic differentiation of human dental pulp stem cells (DPSCs) by upregulating the 
expression levels of the odonto/osteogenic-specific genes.[20] Additional studies with 
bECM hydrogel scaffolds have shown the efficacy of bone-derived ECM hydrogels with 
incorporated growth factors to augment bone formation within the ex vivo chick femoral 
defects.[3,4] Moreover, Gothard et al. showed that alginate/bECM hydrogel scaffolds in 
combination with adult human bone marrow stromal cells (HBMSCs) were able to 
provide in vivo tissue mineralisation and bone formation.[21]  
 
Recently, DPSCs have been considered as a source of cells for bone engineering due to 
their availability and high capacity of in vitro expansion.[12,22,23] Moreover, DPSCs are 
able to differentiate into bone-like tissues when seeded on scaffolds in animal models 
[24,25] and are able to regenerate bone in human grafts.[26,27] Taken together, these 
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studies prompted us to analyse whether a combination of DPSCs and bECM could be 
used as bone graft substitute for the treatment of bone defects. Therefore, the objective of 
the current study was to examine the osteogenic capacity of the decellularized bECM 
hydrogel scaffolds derived from bovine bone using DPSCs. To that end, DPSCs/bECM 
hydrogel constructs have been compared to Col-I, the most commonly purified ECM 
component. Col-I hydrogels at the same concentrations were used as a comparator for 
three reasons. Firstly, it is the most abundant ECM protein in many adult tissues, 
including bone, and is easily extracted using enzymatic or acidic methods.[28] Secondly, 
collagen-based scaffolds are among the most extensively used scaffolds in the clinical 
application with different forms including native, cross-linked and gel forms.[29] Thirdly, 
purified Col-I derived scaffolds are FDA approved for several clinical applications.[30]  
Growth factors such as FGFb [31,32] and EGF [32,33] have been used to promote 
osteogenic differentiation of DPSCs. We hypothesised that the combination of bECM 
hydrogels with growth factors or osteogenic supplements could more effectively induce 
the osteogenic differentiation of human DPSCs than bECM hydrogels alone. Thus, the 
first aim of this study was to evaluate if bECM hydrogels are sufficient to induce 
osteogenic differentiation of DPSCs without the addition of osteogenic supplements. The 
second was to determine if osteogenic supplements or growth factors were able to 
enhance osteogenic differentiation of DPSCs/bECM hydrogel constructs. To these ends, 
we analysed the effects of bECM hydrogel scaffolds upon osteogenic differentiation of 
DPSCs in the presence or absence of extra osteogenic inducers (growth factors or 
osteogenic medium), by observing changes in osteo-specific genes and protein 
expression.  
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2. Materials and Methods  
 
2.1. Hydrogels preparation 
 
Decellularized and demineralized bECM was prepared from bovine bone as described 
previously.[3,4,19-21] Briefly, liquid nitrogen was used to freeze and fragment bovine 
cancellous bone. Then, cancellous fragments were subsequently demineralized using a 
solution of 0.5 M HCl at RT for 24h. After demineralization, a solution of 
chloroform/methanol was used to remove lipids. Then, demineralized powder was 
decellularized by 24h of agitation in 0.05% Trypsin/0.02% EDTA at 37°C, 5% CO2. To 
obtain bECM digests, powdered demineralized and decellularized bone was combined 
with 1 mg/mL pepsin in 0.01 M HCl for a final concentration of 10 mg/mL. Then, the 
suspension was stirred at RT for 96h.  
Gelation of bECM was achieved by neutralizing the pH and salt concentration of the 
pepsin digests at 4 °C followed by incubation at 37 °C for 1h (Supplemental material, 
Figure S1) as previously described.[19] Neutralization of the required digest volume 
occurred by addition of one tenth of the digest volume of NaOH (0.1 N) and one-ninth of 
the digest volume of PBS (10X). To determine whether different concentrations of bECM 
could influence the osteogenic differentiation of DPSCs, we prepared different 
concentrations of bECM. In addition, due to the fact that type I collagen is currently 
considered the gold standard in the field of tissue engineering,[34] we prepared hydrogel 
scaffolds at the same concentrations of Col-I (Supplemental material, Figure S2). 
Concentrations of 3, 4, 6 and 8 mg/mL bECM were prepared at 4 °C and transferred to 
plates. Col-I hydrogels used in this work were made following manufacturer’s 
instructions (Corning). 
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2.2. Rheological characterization of bECM hydrogels 
 
The rheological characteristics of bECM and collagen type I hydrogels were determined 
using a Physica MCR 301 rheometer (Anton Paar, Hertford, UK). Pre-gel solutions at 
4oC were placed between 50 mm parallel plates separated by a 0.2 mm measuring gap.  
The plates were pre-cooled within a humidified chamber to 4oC and were then warmed 
to 37oC during the first 75 seconds of each measurement run. A 20-minute time course 
experiment was performed, during which the samples were subjected to an oscillatory 
strain of 1% at a constant angular frequency of 1 rad s-1 with readings taken every 30 
seconds. 
 
2.3. Dental pulp stem cell cultures 
 
The protocol for the isolation of dental pulp stem cells (DPSCs) was approved by the 
Ethical Committee of Calabrodental Dental Clinic, Crotone, Italy. All subjects enrolled 
in this research have responded to an Informed Consent which has been approved by the 
Ethical Committee of Calabrodental Dental Clinic (ethical agreement number CBD-
008/TRI/2015). Human third molars were extracted from healthy donors (age 20-25).  
DPSCs were isolated as previously described.[20] Briefly, teeth were immersed and 
washed twice using antibiotics (100 U/mL penicillin and 100 μg/mL streptomycin). The 
dental pulp tissue was separated from crown and root using an excavator. Then, the tissue 
was washed twice with sterile PBS and dissected with a scalpel into small pieces. 
Subsequently, to generate single cells suspension, pulp fragments were dissociated 
enzymatically with type I collagenase (3 mg/mL) and dispase (4 mg/mL) for 60 minutes 
at 37°C. Then, the cell suspension was filtered through 70 μM Falcon strainers (Becton 
Dickinson). After filtration, cells were pelleted, seeded on culture dishes, and incubated 
in alpha-MEM culture medium supplemented with 10% foetal bovine serum (FBS; 
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Invitrogen), 2 mM glutamine (Gibco), 100 U/mL penicillin, and 100 mg/mL streptomycin 
(Invitrogen). Cells were incubated at 37°C and 5% CO2 and the medium was changed 
every 48h. 
In this study, we used CFU-F derived cells capable of differentiating in at least three 
mesenchymal lineages in vitro. To generate CFU-F enriched cultures, cells were seeded 
at low density and cultured until colonies appeared. All the colonies were then trypsinized 
and further expanded in culture. Cells from passage 2-4 were employed in the study. The 
multi-differentiation capacity of these stem cells in different inductive media was 
demonstrated in our previous studies.[35,36] 
2.4. DPSC seeded hydrogels 
 
Once the hydrogels were formed, 0.5 X 105 DPSCs in a 1 ml suspension were added to 
the surface of the gels (Supplemental material, Figure S3). Twenty-four hours after 
seeding, the culture medium was replaced with basal medium, osteogenic medium or 
medium supplemented with growth factors (GFs) every 24 hours in the first two days of 
preparation and then every second day after that. Subsequently, the DPSCs/bECM or 
DPSCs/Col-I hydrogel constructs were cultured for 3 weeks. The basal medium was 
composed of α-MEM supplemented with 10% foetal bovine serum (FBS), 2 mM 
glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin as described above for 
DPSCs isolation.[20] Osteogenic medium was composed of α-MEM, 20% FBS, 0.2 mM 
L-ascorbic acid-2-phosphate (Sigma), 100 nM dexamethasone (Sigma), 10 mM β-
glycerophosphate (Sigma), 100 U/mL penicillin, 0.1 mg/mL streptomycin, and 0.25 
mg/mL amphotericin B.  The growth factor-supplemented medium was composed of α-
MEM, 10% FBS, 20 ng/mL Epidermal Growth Factor (EGF, Invitrogen) and 40 ng/mL 
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Fibroblast Growth Factor-basic (FGFb, Invitrogen). DPSCs were seeded on Col-I 
hydrogels with the same protocol used for the bECM hydrogels. 
2.5. Live/Dead Staining  
 
DPSCs/hydrogel constructs 3, 7, 14 and 21 days post seeding (n=24) were incubated with 
live/dead staining solution that was composed of fluorescein diacetate (1 μg/mL) and 
propidium iodide (20 μg/mL) at RT for 20 minutes. Then, cells were monitored using a 
Leica TCS/SP2 confocal microscope system. Cell viability has been measured by 
Accuchip cell counter kit using the PI standard method of dead-cell staining combined 
with advanced image analysis (Adam, Nanoentek). Briefly, bECM or Col-I hydrogels 
containing cells (n=24) were rinsed three times with PBS and digested with 1 ml of a 
solution containing 3 mg/mL type I collagenase (Gibco) and 4 mg/mL dispase (Gibco) in 
HBSS for 60 minutes at 37°C with regular agitation. Then, recovered DPSCs were 
centrifuged and analysed by Accuchip cell counter kit.  
2.6. Flow cytometry analysis 
 
DPSCs cultured on bECM were analysed for the expression of MSC-related cell surface 
markers as previously described.[20,36,37] Briefly, 5X105 DPSCs were stained with 
FITC/PE/APC-conjugated primary antibodies on ice for 30 minutes prior to being 
analysed on a NAVIOS instrument (Beckman Coulter). The antibodies used were PE 
mouse anti-human CD13, APC mouse anti-human CD29, FITC mouse anti-human CD44, 
FITC mouse anti-human CD73, PE mouse anti-human CD90, APC mouse anti-human 
CD105, PE mouse anti-human CD146, APC-H7 mouse anti-human CD45 and PE mouse 
anti-human HLA-DR. All fluorochrome-conjugated antibodies used were purchased from 
Becton Dickinson (BD). Mouse IgG1-FITC, IgG1-PE, IgG1-APC and IgG1-APC-H7 
were used as isotype controls.  
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For intracellular staining of osteopontin (OPN), osteocalcin (OSC) and bone sialoprotein 
(BSP),[38] bECM or Col-I Hydrogels containing cells were washed three times in PBS, 
and digested with 1 ml of solution containing 3 mg/mL type I collagenase (Gibco) and 4 
mg/mL dispase (Sigma) in Hank’s Balanced Salt Solution (HBSS) for 1 h at 37°C with 
regular agitation. Recovered cells were centrifuged, washed and fixed with 4% (w/v) 
paraformaldehyde (Sigma) for 20 minutes at 4°C and then permeabilized with a solution 
containing 0.1% Triton X-100 (Sigma) in PBS for 5 minutes. After blocking with 3% 
bovine serum albumin (BSA; Sigma) for 30 min at RT, the cells were washed and 
incubated with indirect or direct fluorescent-conjugated antibodies. The primary 
antibodies used were: Phycoerythrin (PE)-conjugated anti-OPN and FITC-conjugated 
anti-OSC (R&D Systems), and rabbit anti-BSP (Abcam). The secondary antibody was 
anti-rabbit FITC purchased from Abcam. For negative controls, cells were stained with 
an isotype control antibody. Cells were labelled with fluorescence-conjugated antibodies 
against OPN, OCN or with isotype controls. For BSP, cells were labelled with an antibody 
against BSP or with isotype control, followed by detection with Alexa 488–conjugated 
secondary antibody. Labelled cells were analysed by flow cytometry using a NAVIOS 
instrument (Beckman Coulter) and all data analysed using FlowJo vX0.7 software. 
Histograms show the geometric mean fluorescence intensity (GMFI). The total number 
of samples used in this assay is shown in Table S1 (supplemental material). n=8 
constructs were used to obtain the results in section 3.3, n=4 were used to obtain the 
results in section 3.4 and n=4 were used to obtain the results in section 3.5. The number 
of controls (TCPS) used in each results section are indicated in Table S1. 
 
 11 
2.7. RNA isolation and quantitative real-time PCR (qRT-PCR) 
 
RNA isolation and qRT-PCR were performed as previously described.[20,39] See 
supplemental material for further details. The specific primers used for the amplification 
of runt-related transcription factor 2 (RUNX-2), bone sialoprotein (BSP), osteopontin 
(OPN), osteocalcin (OCN) and HPRT are shown in Table 1. n=24 constructs were used 
to obtain the results in section 3.3, n=12 were used to obtain the results in section 3.4 and 
n=12 were used to obtain the results in section 3.5. The number of controls (TCPS) used 
in each results section are indicated in Table S1. 
 
2.8. Immunofluorescence analysis 
 
DPSCs were cultured on bECM hydrogels (3, 4, 6, 8 mg/mL) and Col-I hydrogels (3, 4, 
6, 8 mg/mL) for 3 weeks (n=24, Table S1). Subsequently, DPSCs/bECM hydrogel 
constructs were rinsed with PBS and fixed in 4% paraformaldehyde for 20 min at RT as 
described previously.[36] After washing three times with PBS, the cells were 
permeabilized with 0.2% Triton X-100 (Sigma) in PBS for 10 min at RT. The cells were 
then washed three times with PBS and blocked with 3% BSA for 30 min at RT. The 
DPSCs/bECM hydrogel constructs were subsequently incubated for 12 h with indirect or 
direct fluorescent-conjugated antibodies at 4°C. The primary antibodies used were FITC-
conjugated anti-OCN (R&D Systems), and rabbit anti-BSP (Abcam). The secondary 
antibody was anti-rabbit FITC purchased from Abcam. For negative controls, cells were 
stained with an isotype control antibody. The cell nuclei were stained with a 1 μg/mL 
solution of 4,6-diamidino-2-phenylindole (DAPI; Sigma) for 5 min. The cells were 
subsequently mounted with anti-fading medium (ProLong Antifade; Invitrogen) and 
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observed by confocal microscopy (Leica; TCS SP5). The samples were not sectioned and 
all images (n>5 fields for sample) were displayed as maximum intensity z-projections. 
 
2.9. Von Kossa Staining 
DPSCs/bECM hydrogel constructs (n=24) cultured for 3 weeks were washed two times 
with phosphate-buffered saline and fixed in 10% formalin prior to incubation with silver 
nitrate. Subsequently, Von Kossa staining kit was used to visualise the formation of the 
mineralized matrix (Bio-Optica).  
 
2.10. Alizarin Red 
DPSCs/bECM hydrogel constructs (n=24) cultured for 3 weeks were washed once with 
PBS and fixed with 4% paraformaldehyde (Sigma) for 15 min at RT. After washing thrice 
with PBS, an aqueous solution of 5 mg/mL Alizarin red S (Sigma) was added to the 
DPSCs/hydrogel constructs for 30 minutes. Then, DPSCs/hydrogel constructs were 
washed twice with H2O for 5 minutes and were analysed by microscopy. 
 
2. 11. Statistical analysis 
 
A total of 208 DPSCs/hydrogel constructs were analysed in this study (Supplemental 
material, Table S1). Results were presented as means ± standard deviations from three 
independent experiments. The significance of differences between groups was evaluated 
by one-way analysis of variance (ANOVA) followed by Dunnett’s test for multiple 
comparisons. Analyses were conducted using the GraphPad Prism software package 
(Graphpad Software Inc). Values were considered statistically significant if P < 0.05. 
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3. Results 
 
3.1. Rheology of bECM hydrogels 
 
Hydrogels were prepared from bECM at concentrations ranging from 3–8 mg/mL (Figure 
1A). The rheological characteristics of the bECM hydrogels were determined using a 
parallel plate rheometer and compared to collagen type I hydrogels of the same 
concentrations (4, 6 and 8 mg/mL).  In each case, the storage (Gʹ) and loss (Gʹʹ) modulus 
of the hydrogels increased after the pepsin digests (or pre-gel collagen type I solutions) 
were neutralized and the temperature was increased from 4°C to 37°C.  Solid-like 
behaviour was confirmed since the storage modulus was greater than the loss modulus by 
a factor of approximately 10 for the bECM hydrogels and a factor of approximately 20 
for the collagen type I hydrogels (Figures 1B, C and D). The bECM and Col-I hydrogels 
showed an increase in rate of gelation with increasing concentration wherein bECM and 
Col-I had storage moduli of 59.3 ± 17.5 Pa and 58.5 ± 5.0 Pa, respectively, at 4 mg/mL 
and 145.1 ± 65.7 Pa and 454.7 ± 101.3 Pa at 8 mg/mL. 
3.2. bECM supports cell attachment and growth of DPSCs 
Human mesenchymal stem cells derived from dental pulp (DPSCs) were first 
characterised using flow cytometry to confirm their mesenchymal phenotype, prior to 
seeding on bECM hydrogels. FACS analysis showed positive expression of cell surface 
markers of MSCs including CD13, CD29, CD44, CD73, CD90, CD105 and CD146. 
Negative expression was demonstrated for CD45 and HLA-DR (Figure 2A). DPSCs were 
seeded onto bECM hydrogels (3, 4, 6, 8 mg/mL), and the distribution of cells was 
compared to those cultured on Col-I hydrogels or tissue culture polystyrene (TCPS). 
DPSCs spontaneously formed aggregates when cultured on 3, 4, 6, 8 mg/mL bECM or 
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Col-I hydrogels compared to TCPS (Figure 2B and supplemental material, Figures S3 
and S4). DPSCs cultured on bECM hydrogels were viable after 21 days as shown by 
live/dead staining (Figure 2C). There were only a few DPSCs that were positive for 
Ethidium homodimer III (supplemental material, Figure S5), signifying low numbers of 
dead cells. Moreover, by day 7 of culture, the percentages of living cells in 3, 4, 6 and 8 
mg/mL bECM hydrogels were 95, 94, 94 and 92%, respectively, with no statistical 
difference compared to Col-I hydrogels or TCPS (3 mg/mL Col-I, 96%; 4 mg/mL Col-I, 
96%; 6 mg/mL Col-I, 94%; 8 mg/mL Col-I, 92%; TCPS, 94%, Figure 2D). 
3.3. bECM hydrogels upregulate early, intermediate and late osteogenic 
markers of DPSCs in basal culture conditions 
To evaluate if the bECM hydrogels influenced the osteodifferentiation of DPSCs, cells 
were cultured in basal medium on the surface of 3, 4, 6, 8 mg/mL bECM and Col-I 
hydrogels for 3 weeks. DPSCs seeded on the flask surface (TCPS) with basal medium or 
osteogenic medium were used as controls. The mRNA expression levels of Runt-related 
transcription factor 2 (RUNX-2), bone sialoprotein (BSP), osteopontin (OPN) and 
osteocalcin (OCN), four markers specific for osteogenic differentiation, were up-
regulated in both bECM (up to 2-, 2.5-, 10- and 8.6-fold, respectively) and Col-I hydrogel 
cultures (up to 1.3-, 1.4-, 9.2- and 6.1-fold, respectively) compared to TCPS cultured in 
basal medium, indicating the suitability of the both hydrogel scaffolds for osteogenic 
differentiation of DPSCs (Figure 3A). However, the expression levels of RUNX-2 and 
BSP were significantly greater on the 4 mg/mL bECM hydrogel compared with Col-I at 
the same concentration. In addition, the expression of mRNA for RUNX-2 and BSP were 
higher on the 4 mg/mL bECM hydrogel (2- and 2.6-fold, respectively) compared to 
DPSCs seeded on TCPS and cultured in osteogenic medium (Figure 3A). Results 
 15 
demonstrated that OCN was strongly upregulated in cells seeded on bECM (up to 8.6-
fold) and Col-I hydrogels (up to 6.1-fold) compared to TCPS cultured in the basal 
medium. Conversely, DPSCs seeded on TCPS and cultured in osteogenic medium 
expressed higher levels of OCN (5.2-fold) compared to both DPSCs/hydrogel constructs 
(Figure 3A).  Protein expression analysis confirmed real-time reverse transcription-PCR 
(qRT-PCR) studies: flow cytometry revealed upregulation of OPN, OCN and BSP in 
DPSCs cultured on both bECM (up to 3.8-, 2.6- and 2-fold, respectively) and Col-I 
hydrogel cultures (up to 4.4-, 1.9- and 1.2–fold, respectively) compared to TCPS (Figure 
3B). Moreover, the protein expression levels of BSP were greater on the 4 mg/mL bECM 
hydrogel (3-fold) compared with Col-I at the same concentration and the expression of 
protein for OPN and BSP were higher on the 4 mg/mL bECM hydrogel (1.5- and 1.4-
fold, respectively) compared to DPSCs seeded on TCPS and cultured in osteogenic 
medium. As previously observed for OCN gene expression, DPSCs seeded on TCPS and 
cultured in osteogenic medium expressed higher levels of OCN protein (up to 2-fold) 
compared to both DPSCs/hydrogel constructs (Figure 3B). 
In addition, immunofluorescence analysis showed the higher protein expression level of 
BSP and OCN in DPSCs cultured on bECM compared to Col-I hydrogels (Figure 3C). 
Moreover, the ability of both DPSCs/hydrogel constructs to form mineralized matrix was 
analysed by using Von Kossa and Alizarin Red staining. Results demonstrated that both 
types of DPSCs/bECM hydrogel constructs were able to form mineral deposits after 3 
weeks of culture (Figures 4A, B). Taken together, the results of the present study 
demonstrated that bECM hydrogels combined with DPSCs are sufficient to induce 
osteogenic differentiation without the addition of osteogenic supplements.  
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3.4. Osteogenic supplements enhance osteogenic differentiation of 
DPSCs/bECM hydrogel constructs. 
 
In order to further assess the effects of the bECM hydrogels on the osteogenic 
differentiation of dental pulp stem cells, we analysed the osteogenic-specific genes 
expression of DPSCs cultured on 4 mg/mL bECM hydrogel after 3 weeks of 
differentiation in osteogenic medium. We decided to use bECM hydrogel at a 
concentration of 4 mg/mL since the gene expression levels of RUNX-2 and BSP were 
increased at concentration.  DPSCs grown in osteogenic medium on a flask surface 
(TPCS), and on 4 mg/mL bECM or Col-I hydrogels cultured in basal medium have been 
used as control conditions. Quantitative RT-PCR analyses (Figure 5A) revealed that the 
expression of RUNX-2, BSP, OPN and OCN were significantly higher in DPSCs seeded 
on bECM hydrogels cultured on osteogenic medium (2.2-, 3.6-, 1.6- and 3.6-fold, 
respectively) than in basal medium (Figure 5A). In DPSCs/bECM hydrogel constructs, 
the expression levels of RUNX-2, BSP and OPN were also considerably higher than cells 
cultured on TCPS with osteogenic medium.  
The expression level of OCN was increased in DPSCs/bECM scaffold constructs cultured 
in the osteogenic medium (3.6-fold) compared to those cultured on basal medium. 
However, the expression of OCN in either bECM or Col-I hydrogels was lower (0.56- 
and 0.27-fold, respectively) than cells cultured on TCPS with osteogenic medium (Figure 
5A). Importantly, DPSCs cultured on 4 mg/mL bECM hydrogel scaffold with osteogenic 
medium stimulated higher upregulation of the osteo-specific genes (OCN, 2.1-fold; OPN, 
1.5-fold; RUNX-2, 1.5-fold) than on 4 mg/mL Col-I hydrogel cultured in identical 
medium. 
To confirm these results, we measured the expression levels of osteogenic proteins in 
DPSCs seeded on 4 mg/mL bECM hydrogel cultured in basal medium or osteogenic 
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medium compared to 4 mg/mL Col-I hydrogel or TCPS by flow cytometry.[38] Analysis 
revealed that the protein expression levels of BSP, OPN and OCN were higher in DPSCs 
seeded on 4 mg/mL bECM hydrogel cultured in the osteogenic medium (3.6-, 1.6- and 
3.7-fold, respectively) than those in basal medium (Figure 5B). Importantly, results show 
that both BSP and OPN protein expression were upregulated in DPSCs grown on 4 
mg/mL bECM (2.62- and 2.4-fold) compared to TCPS-cultured cells treated with 
osteogenic medium. Moreover, the protein expression levels of BSP were greater on the 
4 mg/mL bECM hydrogel cultured in osteogenic medium (3-fold) compared with Col-I 
in the same culture conditions. 
3.5. Growth factors affect the osteogenic differentiation of DPSCs in 
combination with bECM hydrogels by upregulating RUNX-2, BSP and 
OCN. 
 
To assess the influence of growth factors (GFs) on the osteogenic potential of 
DPSCs/hydrogel constructs, we evaluated the expression of osteo-specific genes in 
DPSCs cultured on 4 mg/mL bECM hydrogels with or without growth factors compared 
to controls. RUNX-2 and BSP mRNA levels of DPSCs cultured on 4 mg/mL bECM 
hydrogel scaffolds supplemented with growth factors increased significantly (2.3- and 
35-fold, respectively) more than those cultured on TCPS in the same culture conditions, 
whereas a significant reduction in the mRNA expression of OPN was detected in DPSCs 
cultured on bECM hydrogels or TCPS with GFs (Figure 6A). Compared to TCPS in the 
presence of GFs, the cells/bECM hydrogel constructs exhibited a significant increase in 
the expression of OCN (2.41-fold). Similar results were obtained for protein expression 
of OPN, OCN and BSP in DPSCs cultured on 4 mg/mL bECM hydrogels (Figure 6B) in 
the presence of GFs with respect to controls (1.9-, 1.44-, and 2.4-fold increase compared 
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to Col-I hydrogels and 5.3-, 5.4- and 1.9-fold increase compared to TCPS cultured in 
medium containing GFs, respectively). These results showed that the osteogenic 
differentiation of DPSCs cultured on bECM hydrogels is maintained also using a medium 
containing growth factors. 
4.Discussion  
 
To overcome the limitations of the existing methods to produce bone graft 
substitutes,[2,40] new strategies include the culture of osteogenic cells on several types 
of scaffolds.[41,42] In this context, dental pulp stem cells (DPSCs) have been shown to 
differentiate into bone-like tissues in animal models when seeded on scaffolds.[43,44] 
Gronthos et al. first isolated and characterised these stem cells [22] from impacted third 
molars demonstrating similarities to human bone marrow stromal cells (BMSCs) and 
suggested their application in musculoskeletal regenerative medicine. Recent studies 
demonstrated that the osteogenic potential of DPSCs was significantly greater than that 
of BMSCs and adipose tissue-derived stem cells (ADSCs).[45,46]  
DPSCs are a potential source for bone tissue engineering and osteogenic capacity of these 
cells has been well demonstrated in vitro and in vivo.[23,26] In fact, different studies have 
shown that DPSCs can differentiate under specific conditions into osteoblasts in vitro, 
and when implanted in immunocompromised animals can restore critical bone defects 
and produce bone.[47,48] Moreover, Papaccio’s group have demonstrated that when 
DPSCs were transplanted into immunocompromised rats, the cells generated tissue 
structures similar to that observed in adult human bone including an adequate blood 
supply.[43] The osteogenic capacity of DPSCs has been utilised in combination with 
different scaffolds to produce bone-like tissues in several promising studies that further 
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indicate the potential of DPSCs for bone regeneration and repair.[49] 
Although DPSCs are available in limited amounts when compared with BMSCs or 
ADSCs, the process of stem cell isolation does not require to sacrifice a healthy tooth. In 
fact, third molars represent the most common source of DPSCs, since these teeth are often 
extracted for orthodontic reasons and are considered to be medical waste.[49,50] 
Moreover, DPSCs can be long-term cryopreserved and recovered; this renders them a 
potentially suitable and reliable source of cells. [51] 
In the current study, we determined the effects of extracellular matrix (ECM) hydrogel 
scaffolds derived from bovine bone (bECM) [19] upon DPSCs cultured in basal 
conditions and in the presence of osteogenic medium or growth factors.  
The results of the present study demonstrate that bECM hydrogels at different 
concentrations supported cell attachment and growth of DPSCs. Moreover, bECM 
scaffolds enhance osteogenic differentiation of human DPSCs by inducing an 
upregulation of osteo-specific genes RUNX-2, BSP, OPN and OCN and the corresponding 
proteins. These bECM hydrogels also improve the mineralized matrix formation of 
DPSCs probably by enhancing the expression of bone glycoproteins such as OPN and 
BSP, both involved in the formation of the mineralized matrix.[52] Importantly, the 
combination of bECM hydrogels with DPSCs is sufficient to induce osteogenic 
differentiation of DPSCs, without requiring additional osteogenic factors. We 
hypothesise that the mechanical properties of bECM, as well as the constitutive molecules 
and the biological activity of degradation products,[19] could be responsible for the 
osteogenic differentiation of DPSCs. Similar results have been shown in another work, in 
which an increase in mRNA expression of osteoblast-related genes was observed in 
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DPSCs seeded on biocoral scaffolds using medium without the addition of other 
substances.[41]  
  
Here, we observed that both BSP and OPN expression were higher in DPSCs/bECM 
hydrogel constructs cultured in basal medium compared to TCPS-cultured cells treated 
with osteogenic medium. However, at the same time, we observed that DPSCs/bECM 
hydrogel constructs expressed lower levels of OCN compared to TCPS cultured in 
osteogenic medium. We postulate that the early and intermediate osteogenic markers 
(RUNX-2, BSP, OPN),[53,54] but not the late osteogenic markers, such as OCN,[55] can 
be efficiently upregulated by bECM. Importantly, we observed also that the expression 
of the osteogenic markers RUNX-2 and BSP were higher in bECM than Col-I hydrogel 
constructs. These results indicate that bECM may be better suited for supporting 
osteogenic differentiation of DPSCs than Col-I hydrogels. We hypothesise that the 
differences observed between bECM and Col-I might be due to the different mechanical 
and biological properties of these scaffolds.[19] In the second part of this study, using a 
combination of GFs containing FGFb and EGF, we have observed that DPSCs seeded on 
bECM have a higher expression of osteogenic markers than those seeded on TCPS or 
Col-I. The results indicate that growth factors are capable of improving the osteogenic 
potential of bECM hydrogels. Collectively, our data show that bECM hydrogel scaffolds 
provide an enhanced environment for the osteogenic differentiation of DPSCs.  
Our previous study demonstrated the potential of the bECM hydrogel scaffolds to 
upregulate the expression of odontogenic specific genes in DPSCs.[20] Here, we found 
that hydrogel scaffolds can also direct the osteogenic differentiation of DPSCs by 
upregulating the expression of the osteogenic markers at both mRNA and protein levels.  
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Although the results support the potential use of our proposed cell-seeded hydrogel 
scaffolds in bone tissue engineering, there is no a positive dose-response relationship 
between protein content in the hydrogels (3, 4, 6, 8 mg/mL) and osteogenic differentiation 
of the cells. We hypothesise that 6 and 8 mg/mL hydrogels contain a high concentration 
of bone-formation inhibitory factors such as sclerostin [56] or others bovine peptides that 
could hamper the osteogenic differentiation of DPSCs. 
The present work is a preliminary study; further investigations are needed to demonstrate 
the biocompatibility and osteoconductivity of the DPSCs/bECM hydrogel constructs in 
vivo. 
 
5. Conclusions 
In this study, we aimed to measure the effect of bECM on osteogenic differentiation of 
DPSCs. Our results demonstrate that bECM hydrogels facilitated a significant 
upregulation of markers involved in osteogenesis, indicating that DPSCs are directed 
towards the osteogenic lineage. The ability of the bECM hydrogel to induce osteogenic 
differentiation of DPSCs without the addition of growth factors makes it an interesting 
biomaterial for bone tissue engineering applications.  
Overall, the findings from our study have shown some encouraging results which provide 
proof-of-principle data suggesting that DPSCs/bECM hydrogel constructs can be used 
for bone regenerative purposes. However, further studies are needed to assess the clinical 
relevance of the DPSCs/bECM hydrogel constructs.  
In conclusion, the DPSCs/bECM hydrogel constructs developed in this study could be 
considered promising candidates for the treatment of bone defects. 
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Supplemental material 
 
Supplemental Materials and Methods: RNA isolation and quantitative real-time PCR 
(qRT-PCR).  
Table S1: Experimental design; treatment conditions, assignment of DPSCs/hydrogel 
constructs and response measures. 
Figure S1. Representative images of bECM hydrogels used in this study. 
Figure S2. Macroscopic appearance of Col-I hydrogels. Scale bar: 1 cm. 
Figure S3. Distribution of DPSCs cultured on bECM (4 and 8 mg/mL). Phase contrast, 
scale bar: 100 μm. 
Figure S4. Distribution of DPSCs cultured on tissue culture polystyrene (TCPS) at 1, 3, 
7 and 14 days. Scale bar: 200 μm. 
Figure S5. Live/dead analysis of cells/scaffold constructs 14 days after cell seeding in 
basal medium, GFs supplemented medium and osteogenic medium. Viable cells stained 
green and dead cells stained red after Calcein/AM-EthD-III staining. Cells were observed 
under fluorescence confocal microscope, scale bar: 100 μm. 
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Tables and Figures  
 
Table 1: Sequences of primers used for qRT-PCR. 
RUNX-2, runt-related transcription factor 2; BSP, bone sialoprotein; OPN, osteopontin; OCN, osteocalcin; 
HPRT, hypoxanthine phosphoribosyltransferase. 
 
 
  
Gene Sequence (5’-3’) NCBI Accession Number 
RUNX-2 Forward:  ATGTGTGTTTGTTTCAGCAGCA NM_001024630.3 
 Reverse:  TCCCTAAAGTCACTCGGTATGTGTA  
BSP Forward:  GCAGTAGTGACTCATCCGAAGAA NM_004967.3 
 Reverse:  GCCTCAGAGTCTTCATCTTCATTC  
OPN Forward:  CAGTTGTCCCCACAGTAGACAC NM_001040058.1 
  Reverse:  GTGATGTCCTCGTCTGTAGCATC  
OCN Forward:  TGAGAGCCCTCACACTCCTC NM_199173.4 
 Reverse:  ACCTTTGCTGGACTCTGCAC  
HPRT Forward:  TGACACTGGCAAAACAATGCA NM_000194.2 
 Reverse:  GGTCCTTTTCACCAGCAAGCT  
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Figure 1. Macroscopic appearance and rheology of bECM hydrogels.  
A) Macroscopic view of bECM hydrogels at 3 mg/mL, 4 mg/mL, 6 mg/mL and 8 mg/mL, 
scale bar = 1 cm. Rheological characterization of bECM and collagen type I hydrogels at 
concentrations of B: 4 mg/mL, C: 6 mg/mL and D: 8 mg/mL. Gelation kinetics were 
determined by monitoring changes in the storage modulus (Gʹ) and loss modulus (Gʹʹ) 
after inducing gelation. Data represent mean ± standard deviation for n = 3. 
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Figure 2. bECM supports cell attachment and growth of DPSCs. 
A) Flow cytometry analysis of MSC surface markers CD13, CD29, CD44, CD73, CD90, 
CD105, CD146, HLA-DR and CD45 for DPSCs cultured on bECM. The percentage of 
positive cells for each marker is shown, and the isotype control is indicated. The logarithm 
of the X-axis represents the intensity of the fluorescent signal, and the number of cells is 
given on the Y-axis. B) Representative distribution of DPSCs cultured on bECM (3, 4, 6, 
8 mg/mL), Col-I hydrogels (3, 4, 6, 8 mg/mL). Cultures were photographed after 3 weeks, 
scale bar=100 μm. Red arrows indicate cell aggregates. C) Live/dead analysis of 
cells/scaffold constructs 3, 7, 14 and 21 days after cell seeding in basal medium or in 
medium containing growth factors (FGFb + EGF) by confocal laser scanning microscopy. 
D) Percentages of cell viability at day 7 of DPSCs cultured on bECM (3, 4, 6, 8 mg/mL) 
hydrogels with respect to Col-I (3, 4, 6, 8 mg/mL) hydrogels or TCPS measured by the 
PI method using cell counter. N.S. Not statistically significant. 
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Figure 3. bECM hydrogels upregulate osteogenic markers of DPSCs in basal culture 
conditions.  
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A) Relative mRNA expression levels of RUNX-2, BSP, OPN and OCN of DPSCs at 3 
weeks measured by qRT-PCR. DPSCs were cultured on bECM and Col-I hydrogels at 
different concentrations (3, 4, 6, 8 mg/mL) in the basal medium compared to those seeded 
on TCPS and cultured in osteogenic medium. Results are represented as fold increase 
compared to the level expressed in DPSCs seeded on TCPS cultured in the basal medium. 
#P < 0.05 when compared to TCPS; &P < 0.05 when compared to 4 mg/mL Col-I 
hydrogel; @P < 0.05 when compared to TCPS cultured in osteogenic medium. B) Flow 
cytometry analysis at 3 weeks of OPN, OCN and BSP proteins expression in DPSC 
populations seeded on bECM (3, 4, 6, 8 mg/mL), Col-I (3, 4, 6, 8 mg/mL) hydrogels or 
TCPS cultured in basal medium compared to those seeded on TCPS cultured in 
osteogenic medium. Cells were labelled with fluorescence-conjugated antibodies against 
OPN, OCN (solid histograms) or with isotype controls (dotted histograms). For BSP, cells 
were labelled with an antibody against BSP (solid lines) or with isotype control (dotted 
lines), followed by detection with Alexa 488–conjugated secondary antibody. Histograms 
show the geometric mean fluorescence intensity (GMFI) expressed as fold increase with 
respect to TCPS. Flow cytometry data were analysed using FlowJo vX0.7 software. C) 
Representative immunofluorescence analysis of DPSCs cultured on 4 mg/mL bECM and 
4 mg/mL Col-I hydrogels stained with OCN and BSP after 3 weeks in basal medium. 
OCN, osteocalcin; BSP, bone sialoprotein. The cell nuclei were stained with DAPI (blue); 
scale bar = 100 μm. 
  
 35 
 
Figure 4. Mineral deposition of DPSCs/bECM and DPSCs/Col-I hydrogel 
constructs. 
 Von kossa (A) and Alizarin Red staining (B) of DPSCs cultured on bECM (3, 4, 6, 8 
mg/mL) and Col-I (3, 4, 6, 8 mg/mL) hydrogels in basal medium after 3 weeks; scale bar 
= 100 μm. 
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Figure 5. Osteogenic supplements enhance osteogenic differentiation of 
DPSCs/bECM hydrogel constructs.  
A) Relative mRNA expression levels of RUNX-2, BSP, OPN and OCN of DPSCs at 3 
weeks measured by qRT-PCR. DPSCs were cultured on 4 mg/mL bECM, 4 mg/mL Col-
I and TCPS cultured in osteogenic medium. Data are represented as fold increase 
compared to the level expressed in DPSCs seeded on TCPS cultured in osteogenic 
medium. @P < 0.05 when compared to TCPS cultured in osteogenic medium; $P < 0.05 
when compared to bECM 4 mg/mL cultured in basal medium and &P < 0.05 when 
compared to Col-I 4 mg/mL cultured in osteogenic medium. B) Flow cytometry analysis 
at 3 weeks of OPN, OCN and BSP expression in DPSC populations seeded on 4 mg/mL 
bECM, 4 mg/mL Col-I and TCPS cultured in osteogenic medium. Cells were labelled 
with antibodies against OPN, OCN and BSP (solid histograms) or with isotype controls 
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(dotted histograms). Histograms show the geometric mean fluorescence intensity (GMFI) 
expressed as fold increase with respect to TCPS cultured in osteogenic medium.  
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Figure 6. GFs affect the osteogenic differentiation of DPSCs in combination with 
bECM hydrogels.  
A) Relative mRNA expression levels of RUNX-2, BSP, OPN and OCN of DPSCs at 3 
weeks measured by qRT-PCR. Cells were cultured on 4 mg/mL bECM or Col-I hydrogel 
scaffolds in medium supplemented with growth factors or basal medium. Data are shown 
as the fold increase compared to the level expressed in DPSCs cultured on TCPS in basal 
medium. #P < 0.05 when compared to TCPS cultured in medium containing GFs; $P < 
0.05 when compared to the respective hydrogels in basal medium; &P < 0.05 when 
compared to TCPS cultured in osteogenic medium. B) Flow cytometry analysis at 3 
weeks of OPN, OCN and BSP expression in DPSCs seeded on 4 mg/mL bECM or 4 
mg/mL Col-I hydrogels cultured in medium containing GFs (growth factors; FGFb + 
EGF) compared to those seeded on TCPS cultured in basal or osteogenic medium. Cells 
were labelled with fluorescence-conjugated antibodies against OPN, OCN (solid 
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histograms) or with isotype controls (dotted histograms). For BSP, cells were labelled 
with an antibody against BSP (solid lines) or with isotype control (dotted lines), followed 
by detection with Alexa 488–conjugated secondary antibody. Histograms show the 
geometric mean fluorescence intensity (GMFI) expressed as fold increase with respect to 
TCPS cultured in the basal medium. Flow cytometry data were analysed using FlowJo 
vX0.7 software. 
 
